Effect of Laser Puncture on Rheumatoid Arthritis Patients

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04684693

Enrollment

Registered

2020-12-24

Start date

2020-12-25

Completion date

2021-01-22

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

Studying the effect of laser puncture on rheumatoid arthritis patients

Interventions

DEVICELaser

Laser puncture and exercise

PROCEDUREControl

Exercise

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

65 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Meeting the criteria of ACR classification for rheumatoid arthritis * Meeting the criteria of EULAR classification for rheumatoid arthritis

Exclusion criteria

* Having malignancy * Having connective tissue disease * Smokers

Design outcomes

Primary

Measure	Time frame	Description
IL-6 (Change)	Pre-intervention, 4 weeks	Plasma interleukin-6 inflammatory markers
ATP (Change)	Pre-intervention, 4 weeks	Plasma ATP concentration anti-oxidant marker
MDA (Change)	Pre-intervention, 4 weeks	plasma malondialdehyde oxidative marker
CRP (Change)	Pre-intervention, 4 weeks	Analysis of serum C-reactive protein
HAQ (Change)	Pre-intervention, 4 weeks	Health Assessment questionnaire
RAQoL (Change)	Pre-intervention, 4 weeks	Rheumatoid Arthritis Quality of Life

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026